USSTOCK.TODAY
Market Closed
Log in Sign up

Johnson & Johnson and Amgen as Dividend Stock Investment Options

The Motley Fool +1 ·

JNJ Johnson & Johnson
$259.36 +2.19%
View chart & analysis →
AMGN +3.29%
  1. 1Johnson & Johnson has increased its dividends for 64 consecutive years.
  2. 2Johnson & Johnson proposed a $5.5 billion settlement regarding talc-related litigation.
  3. 3Amgen recorded $10.1 billion in second-quarter revenue, achieving a 10% year-over-year revenue growth rate.

So what's the key point?

Johnson & Johnson has raised its dividends for 64 years and proposed a $5.5 billion settlement for lawsuits. Amgen recorded $10.1 billion in second-quarter revenue, growing 10% compared to the previous year.

Source The Motley Fool +1 · View original ↗

Related 3-line summaries

Rapport Therapeutics shares surge over 50% in Tuesday pre-market trading following successful Phase 2 trial InvestorsHub +3 · 15h agoJohnson & Johnson shares fall following third-quarter earnings release The Motley Fool +1 · 3d agoComparing Fidelity MSCI Health Care Index ETF and iShares Biotechnology ETF The Motley Fool +1 · 6d ago
Today's 5 AI picks, all free
Nothing hidden: past picks and how they did against the S&P 500.
See today's picks →
← Back to news